Aurinia Pharmaceuticals Inc (AUPH)
US$ 7.83-0.51%
Price Chart
Key Statistics
Market Cap
$ 1.12B
P/E Ratio
204.50
Revenue (TTM)
$ 235.13M
Volume
1.27M
52W High
$ 10.67
52W Low
$ 4.92
Dividend Yield
0.00%
Beta
1.22
Technicals
50-Day MA
8.024
200-Day MA
7.5602
52 Week High
10.67
52 Week Low
4.92
About AUPH
Aurinia Pharmaceuticals Inc. is a biopharmaceutical company that engages in delivering therapies to people living with autoimmune diseases with high unmet medical needs.
Employees
130
Headquarters
Edmonton, AB
CEO
Mr. Peter S. Greenleaf M.B.A.
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg